dc.contributor.author | Eigentler, Thomas | |
dc.contributor.author | Garbe, Claus | |
dc.date.accessioned | 2025-09-19T15:09:42Z | |
dc.date.available | 2025-09-19T15:09:42Z | |
dc.date.issued | 2025 | |
dc.identifier.issn | 2059-7029 | |
dc.identifier.uri | http://hdl.handle.net/10900/170346 | |
dc.language.iso | en | de_DE |
dc.publisher | Amsterdam : Elsevier | de_DE |
dc.relation.uri | http://dx.doi.org/10.1016/j.esmoop.2025.105053 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20250630000000_00658 | |
utue.personen.roh | Livingstone, E. | |
utue.personen.roh | Gogas, H. J. | |
utue.personen.roh | Kandolf, L. | |
utue.personen.roh | Meier, F. | |
utue.personen.roh | Eigentler, T. K. | |
utue.personen.roh | Ziemer, M. | |
utue.personen.roh | Terheyden, P. | |
utue.personen.roh | Gesierich, A. | |
utue.personen.roh | Herbst, R. A. | |
utue.personen.roh | Kaehler, K. C. | |
utue.personen.roh | Ziogas, D. C. | |
utue.personen.roh | Mijuskovic, Z. . | |
utue.personen.roh | Garzarolli, M. | |
utue.personen.roh | Garbe, C. | |
utue.personen.roh | Roesch, A. | |
utue.personen.roh | Ugurel, S. | |
utue.personen.roh | Gutzmer, R. | |
utue.personen.roh | Gaudy-Marqueste, C. | |
utue.personen.roh | Kiecker, F. | |
utue.personen.roh | Utikal, J. | |
utue.personen.roh | Hartmann, M. | |
utue.personen.roh | Miethe, S. | |
utue.personen.roh | Eckhardt, S. | |
utue.personen.roh | Zimmer, L. | |
utue.personen.roh | Schadendorf, D. | |
dcterms.isPartOf.ZSTitelID | Esmo Open | de_DE |
dcterms.isPartOf.ZS-Issue | 5 | de_DE |
dcterms.isPartOf.ZS-Volume | 10 | de_DE |
utue.fakultaet | 04 Medizinische Fakultät | de_DE |
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |